Pay in 4 interest-free payments of $5.04 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Jaclyn Bjorklund of Louisiana accuses Novo Nordisk, the maker of Ozempic, and Eli Lilly, which makes Mounjaro, another Type 2 diabetes treatment being used off-label for weight loss, of failing to warn or adequately warn of all the possible adverse side effects from using the medications, including the risk of gastroparesis, also known as paralyzed stomach. Bjorklund, 44, was diagnosed with Type 2 diabetes in 2017 and used Ozempic for more than one year, then stopped and switched to Mounjaro in July 2023 with both drugs prescribed by her doctors to control her blood sugar, according to court papers
That meant doctors could legally prescribe cheaper compounded versions of semaglutide and tirzepatide with the same active ingredients as the originals
The liver then synthesizes triglycerides and cholesterol and releases them as VLDL
Our doctors can help
At Bare Necessities, youre seen by a Board-Certified Nurse Practitioner not shuffled through an app or a call center
Ongoing Maintenance (Years 2-5) Research shows many people regain significant weight when discontinuing semaglutide
US$ 27.82
US$ 23.88
US$ 29.21
US$ 25.79
US$ 21.40
